GSK

2 catalysts · 1 upcoming · 0 awaiting · 1 resolved

Upcoming

[PDUFA]·Apr 30, 2026
T-1d

Islatravir (MK-8591D) and Lenacapavir - (ISLEND) (GILD) PDUFA — Human immunodeficiency virus (HIV)

▸ analysis · bull/bear · base rate — pro

Resolved

[PDUFA]·May 31, 2024
→ FAVORABLE

mRNA-1345 (mResvia) — RSV vaccine for adults 60+

▸ analysis · bull/bear · base rate — pro